Novel group of tyrosyl-DNA-phosphodiesterase 1 inhibitors based on disaccharide nucleosides as drug prototypes for anti-cancer therapy

A new class of tyrosyl-DNA phosphodiesterase 1 (TDP1) inhibitors based on disaccharide nucleosides was identified. TDP1 plays an essential role in the resistance of cancer cells to currently used antitumour drugs based on Top1 inhibitors such as topotecan and irinotecan. The most effective inhibitor...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Enzyme Inhib Med Chem
Main Authors: Komarova, Anastasia O., Drenichev, Mikhail S., Dyrkheeva, Nadezhda S., Kulikova, Irina V., Oslovsky, Vladimir E., Zakharova, Olga D., Zakharenko, Alexandra L., Mikhailov, Sergey N., Lavrik, Olga I.
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2018
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6136360/
https://ncbi.nlm.nih.gov/pubmed/30191738
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14756366.2018.1509210
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados